MARKET

CRDL

CRDL

Cardiol Therapeu
NASDAQ
1.080
+0.005
+0.47%
Opening 09:51 05/08 EDT
OPEN
1.070
PREV CLOSE
1.075
HIGH
1.090
LOW
1.069
VOLUME
22.14K
TURNOVER
--
52 WEEK HIGH
3.120
52 WEEK LOW
0.7709
MARKET CAP
89.22M
P/E (TTM)
-3.0244
1D
5D
1M
3M
1Y
5Y
1D
Weekly Report: what happened at CRDL last week (0428-0502)?
Weekly Report · 3d ago
Promising Prospects for Cardiol Therapeutics: Buy Rating Backed by Strong Market Potential and Innovative Treatment Developments
TipRanks · 05/01 10:56
Cardiol Therapeutics Nominates Dr. Timothy Garnett to Board Amid Phase III Trial Progress
TipRanks · 04/29 11:58
Cardiol Therapeutics Nominates Dr. Timothy Garnett to Its Board of Directors
Newsfile · 04/29 11:27
Stocks in play: Cardiol Therapeutics Inc.
Barchart · 04/29 09:17
Cardiol Therapeutics Schedules Virtual Annual General Meeting for May 2025
TipRanks · 04/28 21:47
Weekly Report: what happened at CRDL last week (0421-0425)?
Weekly Report · 04/28 09:54
Cardiol Therapeutics Stock: Is Cannabis Potential Priced In?
NASDAQ · 04/22 11:21
More
About CRDL
More
Cardiol Therapeutics Inc. is a clinical-stage life sciences company. The Company is focused on the research and clinical development of anti-inflammatory and anti-fibrotic therapies for the treatment of heart disease. Its lead drug candidate, CardiolRx (cannabidiol) oral solution, is pharmaceutically manufactured and in clinical development for use in the treatment of heart disease. It is recognized that cannabidiol inhibits activation of the inflammasome pathway, an intracellular process known to play an important role in the development and progression of inflammation and fibrosis associated with myocarditis, pericarditis, and heart failure. It is also developing CRD-38, a novel subcutaneously administered drug intended for use in heart failure. It has received Investigational New Drug Application authorization from the United States Food and Drug Administration to conduct clinical studies to evaluate the efficacy and safety of CardiolRx in two diseases affecting the heart.
Recently
Symbol
Price
%Change

Webull offers Cardiol Therapeutics Inc stock information, including NASDAQ: CRDL real-time market quotes, financial reports, professional analyst ratings, in-depth charts, corporate actions, CRDL stock news, and many more online research tools to help you make informed decisions. Trade stocks for 0 commission and 0 contract fees on the web version for easy and convenient access, or download the Webull app and trade on the go.

You can practice and explore trading CRDL stock methods without spending real money on the virtual paper trading platform.